Target intelligence / Profile preview

Bacteriorhodopsin (bR)

Target
bR
Molecular classification
Microbial rhodopsin, Light-driven proton pump, Seven-transmembrane protein, Transporter
01

Overview

Bacteriorhodopsin is a light-driven proton pump found in the purple membrane of the archaeon Halobacterium salinarum (UniProt: P02945). It consists of a seven-transmembrane protein, bacterio-opsin, and a covalently bound retinal chromophore attached via a Schiff base to a lysine residue (Ernst et al., 2014). Upon the absorption of light, the retinal undergoes photoisomerization from an all-trans to a 13-cis configuration, which triggers a series of conformational changes known as the photocycle (Lanyi, 2004). This process results in the active transport of protons from the cytoplasm to the extracellular space, creating an electrochemical gradient used for ATP synthesis. While not a native human protein, it is a primary model system for studying G protein-coupled receptors (GPCRs) and membrane protein dynamics. In therapeutic research, bacteriorhodopsin and its derivatives are investigated for optogenetic applications, such as restoring light sensitivity in degenerate retinal cells (Busskamp et al., 2010). It is also utilized in biotechnology for optical switching and high-density data storage due to its robust stability and unique photochemical properties.

Other names
Bacterio-opsinPurple membrane proteinRetinal-bound bacterio-opsin
02

Mechanism of action

Light-induced photoisomerization of the retinal chromophore from all-trans to 13-cis, driving a conformational change that pumps protons across the cell membrane (Lanyi, 2004; Ernst et al., 2014).

03

Biological functions

Light-driven proton transportElectrochemical gradient generationATP synthesisPhototrophy
04

Disease associations

Retinal degenerationVision loss
05

Safety considerations

Immunogenicity of archaeal proteins in human tissuePhototoxicity from high-intensity light activationPotential for unintended cellular acidification
06

Interacting drugs

All-trans-retinal

2 more in the full profile.

Beyond the preview

Go deeper on Bacteriorhodopsin (bR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacteriorhodopsin (bR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call